Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart vs Human Insulin in Children < 7 with T1D
NCT00571935Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2003
- Primary completion
- Oct 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Glycated Hemoglobin A1c at 26 weeks. Started Aug 2003; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00571935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571935.